Answers are grounded in this paper and cite their sources.
Investigation unveils that 7-ketocholesterol decreases hyaluronic acid production in smooth muscle cells, suggesting implications for arterial stiffness.
Background: Hyaluronic acid (HA) is a component of the soft extracellular matrix in the arterial wall, and is involved in the elasticity of the arterial wall; however, its regulation and role in the progression of atherosclerosis remain unclear. We investigated the effects of 7-ketocholesterol (7KCHO), an oxysterol found in the atheromatous lesion, on the synthesis of HA in the cultured human smooth muscle cells (SMCs). Methods: The cell count was done using a hemocytometer. Messenger ribonucleic acid (mRNA) and protein “hyaluronic acid synthase 2 (HAS2)" was measured by real-time reverse transcription polymerase chain reaction (RT-PCR) and Western blot, respectively. Production of the intracellular reactive oxygen species (ROS) was measured by fluorescence-activated cell sorting. Results: Treatment with 7KCHO increased ROS and decreased HA production in SMCs. N-acetyl cysteine, an antioxidative compound, restored the 7KCHO-induced decrease in the HA production. No changes were observed in the mRNA and protein expression of HAS2 by 7KCHO treatment. Conclusions: These results suggest that HA production is decreased by 7KCHO treatment through stimulation of ROS. The 7KCHO-induced decrease of HA production may be involved in the loss of elasticity and the enhancement of arterial stiffness.
No takes yet. Share an insight, caveat, or question.
Ayako et al. (2018) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: